The higher fecal IL-8 and lower IL-10 concentration in COVID-19 patients compared to controls and the higher IL-23 in patients with severe disease point to some degree of immunological involvement of the GI tract in SARS-CoV-2 infection. This evidence concerns the gene CXCL8 and COVID-19.